Carra Simpson

Carra Simpson is an experienced professional in the field of neuropsychiatry, currently serving as the Associate Director and Scientific Learning Lead at Bristol Myers Squibb since October 2024. Previously, Carra held the position of Senior Medical Science Liaison in Psychiatry at AbbVie, where significant contributions were made in leading Medical Affairs for schizophrenia and supporting the launch of a new indication for cariprazine. Carra's academic background includes a role as a Research Scholar at the University of California, Los Angeles, focusing on neurobiology and microbiome research, as well as various positions at the University of Melbourne, including Academic Teacher and Clinical Research Coordinator. Carra's educational qualifications include a PhD in Biological Psychology from the University of Melbourne and a Graduate Certificate in Biomedical Science from the University of New England.